Manke Isaac's Insider Trades & SAST Disclosures
Manke Isaac's most recent trade in OnKure Therapeutics Inc. - Ordinary Shares - Class A was a trade of 3,469 Class A Common Stock done . Disclosure was reported to the exchange on March 31, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Manke Isaac.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| OnKure Therapeutics Inc. -... | Isaac Manke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2025 | 3,469 | 3,469 | - | 0 | Class A Common Stock | |
| Q32 Bio Inc. | Isaac Manke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 19,008 | 19,008 | - | - | Stock Option (Right to Buy) | |
| Q32 Bio Inc. | Isaac Manke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 19,008 | 19,008 | - | - | Stock Option (Right to Buy) | |
| Q32 Bio Inc. | Isaac Manke | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Jan 2025 | 19,008 | 0 | - | - | Stock Option (Right to Buy) | |
| Q32 Bio Inc. | Isaac Manke | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Jan 2025 | 12,767 | 0 | - | - | Stock Option (Right to Buy) | |
| Q32 Bio Inc. | Manke Isaac | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 12,767 | 12,767 | - | - | Stock Option (Right to Buy) | |
| Q32 Bio Inc. | Isaac Manke | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Jan 2025 | 2,627 | 0 | - | - | Stock Option (Right to Buy) | |
| Q32 Bio Inc. | Manke Isaac | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 2,627 | 2,627 | - | - | Stock Option (Right to Buy) | |
| OnKure Therapeutics Inc. -... | Isaac Manke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 15,300 | 15,300 | - | - | Stock Option (right to buy) | |
| Q32 Bio Inc. | Isaac Manke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Mar 2024 | 12,767 | 12,767 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges